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Abstract: Framework: Healthcare project finance (PF) involves long-term structural investments in 
hospitals, typically within a public–private partnership (PPP). Banks represent the third major 
stakeholder, supporting the private player. Within this well-known framework, digital platforms 
represent a new virtual stakeholder, operating as a bridging node that incorporates information, 
and eases transactions. The relationships among the stakeholders are re-engineered around the plat-
form and may be expressed with network theory patterns, even considering its multilayer exten-
sions. Justification: As these investments are highly leveraged, especially during the construction 
phase, bankability represents a major sustainability concern. Objective: The research question is fo-
cused on the savings deriving from the introduction of networked digital platforms, and on their 
impact on bankability, shaping a new PPP model. Methodology: The study is conducted through (a) 
an economic–financial sensitivity analysis where digital savings impact on key PF parameters, in-
cluding bankability; (b) a mathematical interpretation, based on network theory, where the stake-
holders of two ecosystems—respectively, without and with a digital platform—are compared. Re-
sults: The creation of a value-adding “pie” anticipates its partitioning among the value co-creating 
stakeholders. This study represents an advance in the field, showing how technological innovation 
may improve the overall bankability and the value creation of leveraged infrastructural invest-
ments, even beyond the healthcare industry. 
Keywords: network theory; scalability; smart healthcare; public–private partnerships (PPP); Value 
for Money; economic sustainability 
 
1. Introduction 
The aging population, public budgetary pressures, worldwide demographic growth, 
and dated infrastructure weaken the capacity of most developing nations to deliver 
proper healthcare services. The healthcare industry is a major industrial sector in numer-
ous countries. There is evidence that health investments promote economic growth [1]. 
Infrastructural healthcare investments are therefore an authoritative pro-growth as well 
as a pro-equity instrument. Healthcare is a highly networked and systemic industry that 
affects projects, which need to be well-positioned in the territory, as shown by the Covid-
19 pandemic [2] and synergic with other infrastructural facilities. 
Public authorities are eager to find innovative solutions to foster sustainable welfare 
and increasingly seek private partners through public–private partnership (PPP) schemes 
[3] whose attractiveness remains disputed [4–8]. Healthcare Project Finance (PF) repre-
sents the financing of long-term infrastructure with a sophisticated financial structure 
where project equity and debt are used to finance the project, rather than to reward project 
sponsors. [9]. 
Although the public proponent remains the key player, deciding strategies and man-
aging healthcare core activities, the private actor performs the Project-Build-Operate-
Transfer (PBOT) functions, within the period of the concession (typically, approximately 
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3 years of project and build, pursued by some 20–25 years of private management of non-
core activities, ending up in a free transfer to the public). The main stakeholders are the 
private and public actors, linked by a contractual agreement (PPP). Other crucial stake-
holders are represented by the banks that sponsor the private initiative (using a PF pat-
tern), the pass-through sub-suppliers, and, last by not least, the patients that mostly inter-
act with the public player. Each stakeholder will be considered to be a “node” connected 
to other stakeholders through “edges”, consistently with network theory analysis repre-
senting an innovative way of interpreting corporate governance interactions. 
The market mechanism that presides over the PPP auction (where private players 
compete to win the bid) is fully consistent with an intensive regulated industry such as 
healthcare and is witnessed by the many empirical cases of new public hospitals built and 
run with PPP/PF agreements [3–10]. 
Pressure for improving quality standards goes along with smart healthcare investments 
that are increasingly patient-centric [10], and risky [11], therefore threatening bankability. 
Bankability concerns the level of willingness of prospective lenders to finance the project, i.e., 
what amount and under what conditions, and is a crucial prerequisite for all the stakeholders 
involved in the infrastructural project-no money from the banks, no new hospital. 
Following this framework, the research question of this study is focused on the sav-
ings deriving from the introduction of networked digital platforms in the PF/PPP mecha-
nism, and on their consequent (positive) impact on bankability that stands out as a pri-
mary feasibility concern (no money, no party). These savings produce a “value pie” that 
can be partitioned among the contributing stakeholders. 
Traditional stakeholders (shareholders, managers, employees, suppliers, financial 
lenders, customers, etc.) are complemented in the healthcare infrastructural industry by 
patients, public procurers, and private suppliers, coalescing around a Special Purpose Ve-
hicle (SPV) that acts as a bridging/hub node. Pivoting digital platforms represent a further 
“virtual” stakeholder [12]. 
This study is, to the author’s best knowledge, innovative, and it might describe both 
the specific healthcare sector, looking for patient-centered satisfaction and sustainability, 
and the traditional stakeholder relationships, re-engineered around digital platforms. 
The research is organized as follows: after these introductory notes, there is a litera-
ture review in Section 2. The methodology is then exposed before an empirical simulation 
of how a typical healthcare PF investment may change when digital platforms are intro-
duced. Impact on bankability is examined. A discussion and conclusion critically examine 
and summarize the main findings. 
2. Literature Review 
This study examines some applications to the specific healthcare industry of network 
governance patterns [13]. As the topic is highly interdisciplinary, this literature review 
illustrates the main streams consistent with each field, to discover how they may interact, 
and which are some tentative research gaps. The main subdivisions are: 
1. healthcare PPP/PF investments; 
2. network theory, digital platforms, and applications to healthcare (to make infra-
structural investments “smart”). 
PPP research, starting from its meaning [14], covers different topics across multiple 
disciplines and is disseminated in many journals [15], also concerning the public admin-
istration discipline [16]. PPP policies are examined in [17]. A global survey of PPP experi-
ences, inspiring PPP guidelines [18] is reported in [19] and [20]. Healthcare PPP surveys 
are reported in [16,21–24]. 
The critical choice between Traditional Procurement (internalized within the public 
player) and outsourced PPP/PF is now a cornerstone of cost–benefit analyses concerning 
complex infrastructural investments. This trade-off is driven by Value for Money (VfM) 
considerations that aim to optimize uneasy choices [9]. Patients are a crucial albeit under-
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investigated stakeholder, positively affected by smart technologies applied to public 
healthcare, which represent a trendy innovation [10]. 
Network theory—to be linked to digital platforms acting as bridging nodes in the 
PPP ecosystem—is explained in [25] whereas network governance applications are exam-
ined in [12,13]. A literature review of digital platforms is contained in [26,27] that analyse 
sharing economy platforms. 
Specific healthcare applications are discussed in [28] that review existing literature 
on digital health innovation ecosystems. Healthcare platforms are in most cases public 
[29], as they support public services for citizens. Healthcare savings due to digitalization 
are growing [30,31]. The impact of healthcare digitalization on smart hospital PF is exam-
ined in [32]. Digital care is characterized by low cost, high tech, and high access. In general, 
digitization creates value [33]. Technology is, however, a double-edged sword and may 
increase costs in healthcare [34,35], although its routine application may allow for savings. 
Although healthcare PPP stakeholdership models have already been investigated in 
the literature, their interaction through innovative digital platforms has been hardly con-
sidered. [36] show that platforms leverage networked technologies to facilitate economic 
exchange, transfer information, and connect people. [37–39] examine [digital] value co-
creation networks that are consistent with a platform-driven PPP ecosystem. 
These studies, however, are not specifically dedicated to the peculiar healthcare in-
dustry, nor they address innovative PPP issues where dyadic public–private interactions 
are extended to multi-lateral and digital networking. 
A short analysis of the main applications of healthcare digital platforms, complemen-
tary to the literature review, is propaedeutic to a critical examination of the bankability 
issues. Table A1 (reported in the Appendix) contains an illustration of some actions and 
strategies that may have a positive socio-economic impact on healthcare strategies, im-
proving overall sustainability. 
The interpretation of the healthcare PPP firm (the private SPV, and its relations with 
the external stakeholders, as the public part, the banks, the patients, etc.) in terms of a 
Coasian nexus of contracts can be generalized to a network of interrelations, following the 
paradigms of network theory and the still pioneering explanation of the interactions 
among PPP stakeholders [13]. Bankability is a crucial PF/PPP milestone (no money, no 
party, …) that can be reinterpreted with these networked digital patterns. 
To the author’s best knowledge, there are no comprehensive studies that analyze the 
research question of this paper, considering how traditional and innovative (digital) 
stakeholders interact in healthcare PPP investments, impacting the project’s bankability. 
This study is therefore intended to fill a gap in the extant literature, targeting the 
healthcare industry that proves highly sensitive to digitalization, a core component of e-
health, m-health, or telemedicine. 
3. Methodology 
As anticipated in the introduction, the research question examines healthcare invest-
ments, considering the (positive) impact of digitalization on their financial and economic 
margins. The purpose is to show that: 
1. Higher margins improve bankability, with a cascade benefit on all the involved 
stakeholders. 
2. The value-adding “pie” sharing among the stakeholders may be conveniently mas-
tered by the networking digital platforms, igniting a value co-creation process. 
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The value-generating process can be exemplified in Figure 1 that shows the conse-
quential networked steps along the value chain and its recursive return to the value-orig-
inating platform (from 4 to 1). In particular, it will be demonstrated that: 
1. Digitalization-driven cost savings positively impact financial and economic 
marginality (proxied by the Earnings Before Interests, Taxes, Depreciation and 
Amortization—EBITDA and other parameters) of the PPP/PF initiative, improv-
ing the networking interaction of the stakeholders. 
2. Better financial marginality improves the bankability of the project, making its 
acceptance likelier. 
3. The additional value “pie” created by digitalization is subdivided among the 
main stakeholders (public; private; patients, etc.). 
4. The interaction among the stakeholders is eased by the digital platform bridging 
properties, fostering the incentive to co-create and then share the additional 
value. 
 
Figure 1. Value-generating Process Ignited by Digital Platforms. 
Figure 1, with its double-sided arrow, shows that value co-creation is a circular pro-
cess since the involved stakeholders (the public investor; the private SPV and their sup-
pliers; the banks that sponsor the SPV, the patients, etc.) have an incentive to foster digi-
talization to monetize its proceeds. 
A sensitivity simulation is based on a “traditional” (platform-free) business plan in-
spired by a generalization of four healthcare PPP/PF investments in Veneto (a North-East-
ern region in Italy): 
- New Hospital Center for Acutes-Monselice-Este (Padua) (2011) [40]. 
- Borgo Trento and Borgo Roma-Verona-Integrated University Hospital (2013) [41]. 
- Cittadella della Salute-Treviso Hospital (2017) [42,43]. 
- New hospital complex of Thiene and Schio (Vicenza) (2012) [44]. 
This case, readapted from [45], represents the basic template for a simulation of the 
impact of digital platforms. Within the forecast income statement, platforms increase oper-
ating revenues and decrease, thanks to managerial savings, the operating expenditure 
(OpEx). Their combined effect fosters operating leverage (the translation of higher revenues 
on operating profits that grow more than proportionally) and improves the EBITDA, ex-
pressed by subtracting monetary OpEx to operating revenues. A higher EBITDA has an im-
mediate positive effect on liquidity generation, debt service capacity, and therefore banka-
bility. 
The analysis will start from the compared “without-with” examination of a straight-
forward network with that of a “smart” platform-driven network where new nodes are 
introduced. This methodology is consistent with the “with or without” differential ap-
proach traditionally used to estimate intangibles (e.g., comparing a firm with or without 
a patent), as illustrated in the International Valuation Standard 210 (par. 80.1). 
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The methodology is based on an empirical case, inspired by a sample of traditional 
healthcare PF investments, where digital savings are introduced with a sensitivity analy-
sis, impacting economic margins, and eventually affecting the overall bankability of the 
project. Two complementary methodologies will be used in the next sub-paragraphs: 
(a) An economic–financial sensitivity analysis, where digital savings impact on key 
PF parameters, including bankability; 
(b) A mathematical interpretation, based on network theory, where the stakeholders of 
two ecosystems—respectively, without and with a digital platform—are compared. 
This interdisciplinary methodology is consistent with the research question, as it al-
lows a comprehensive description of the impact of digital savings, and can be applied to 
other PPP investments, even beyond the healthcare industry. Network theory gives an 
innovative reinterpretation of the interactions among the main PPP stakeholders. 
3.1. From Standard to Smart Healthcare PF: A Sensitivity Simulation 
An empirical analysis of the impact of digitalization of healthcare long-term invest-
ments, such as those concerning new hospitals built and managed with PPP/PF agree-
ments, is still missing, due to the novelty of the topic. The simulation will therefore be 
conducted starting from a generalized case of four Veneto-based hospitals realized with 
PF/PPP agreements (recalled in paragraph 3), analyzing the potential repercussion of dig-
italization on the revenues and costs of the private entity (SPV). 
This empirical setting is consistent with the research question, as it provides a theoretical 
story of the main accounting and financial indicators that preside over the bankability issues, 
and the interrelations among the stakeholders. The sensitivity analysis, with the impact of dig-
italization, shows the potential effect of digital savings on the life-long parameters of the in-
vestment, consistently with the “without or with (digitalization) approach” indicated in the 
methods and illustrated in the comparison between Figures 2 and 3. 
The income statement of the SPV is the “engine” behind any bankability considera-
tion since it is within this accounting prospect that perspective economic margins are fore-
cast, leading to liquidity creation and consequent debt service (the key concept behind 
any bankability issue). 
The hypothetical impact on operating revenues and costs is the following: 
1. a scenario with +20% revenues / −20% costs; 
2. a scenario with +15% revenues / −15% costs; 
3. a scenario with +10% revenues / −10% costs; 
4. a scenario with +5% revenues / −5% costs; 
5. a scenario with +2% revenues / −2% costs. 
This sensitivity impact is estimated considering the potential repercussion on reve-
nues and operating costs of healthcare-related digital platforms, as shown in Table A1 in 
the Appendix. Any increase in the revenues or decrease in the operating costs (OpEx) 
driven by digitalization, improves financial and economic marginality, with a positive 
impact on bankability and value creation. 
Economic margin improvements are likely to be substantial and self-fulfilling. This 
may for instance happen when bundling intangible applications within the platform (e.g., 
collecting healthcare big data from the Internet of Things (IoT) or other sensors, storing 
them in the cloud using interoperable databases, validating sensitive health data with 
blockchains, and then proceeding to their interpretation with artificial intelligence algo-
rithms). 
Although this variability in revenues and costs that inspires the sensitivity analysis 
is not backed by still unavailable empirical evidence, it seems reasonable since the com-
bined use of bundled intangibles may bring to over 10% variations both in (higher) reve-
nues and (lower) costs. This variability is consistent with [46] according to which the po-
tential benefits of using big data in analyzing operations management and supply chain 
activities bring to a 15–20% increase in Return on Investment (ROI), productivity, and 
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competitiveness. A McKinsey study [47] shows that big data may reduce US healthcare 
costs by about 8%. This indicates the importance of data mining and predictive analytics 
for more informed decision-making in supply chain management and operations [48,49]. 
The hypothesis that indicates a (meaningful) cost reduction is also consistent with 
the targets of an optimal healthcare standard cost policy, where purchase prices are inter-
mediated and benchmarked using B2B digital platforms. A comparison among different 
hospitals, coordinated at the Regional level, shows the difference between each local 
spending policy and the optimal benchmark inspired by a shared sample. Standard 
healthcare costing is the foundation for controlling operational performance. 
A brief comparison is illustrated in Table 1. Applying a sensitivity analysis to the 
base case, 2%, 5%, 10%, 15%, and 20% growth in operating revenues (and a corresponding 
reduction in operating costs, mostly monetary OpEx) are reported in each column. 
The first data column illustrates the base case of a standardized healthcare PF of 3 
years (considering the project and construction phase) + 25 years of operations, where 
main input data refer to: the revenues of the SPV (availability payment from the public 
procurer + hot/cold revenues) yearly; the investment amount, backed by the equity and 
the debt; the crucial financial/macroeconomic variables (interest rates, inflation, etc.) that 
are not affected by digitalization. 
Table 1. Impact of Digitalization on the Project Finance main parameters. 
 
 
 Base case 
















Extension of the PF concession (years) 28 28 28 28 28 28 
Yearly Availability Payment (*) (€) 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 
Yearly Service Revenues (*) (€) 18,675,000 18,675,000 18,675,000 18,675,000 18,675,000 18,675,000 
Yearly Commercial Revenues (€) (*) 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 
Fixed Investment Sum (€) (#) 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 
Public Grants (€) (#) 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 50,000,000 
Equity (Share Capital) (€) 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 
Subordinated Financial debt (€) 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 
Senior Financial debt (€) 46,978,861 47,541,094 47,388,242 47,243,758 47,107,383 47,029,344 
Average Inflation Rate (%) 3 3 3 3 3 3 
Senior Financial debt Rate (%) 5.81 5.81 5.81 5.81 5.81 5.81 
Subordinated Financial debt Rate (%) 6.06 6.06 6.06 6.06 6.06 6.06 
Total Financial Charges (€) 40,334,867 40,657,903 40,570,070 40,487,052 40,408,700 40,363,868 
Net Present Value (NPV)equity (€) 17,229,881 1,210,460,994 492,869,901 196,306,265 71,562,595 33,909,517 
Net Present Value (NPV)project (€) 30,034,485 1,898,642,621 773,383,379 309,151,060 114,349,865 55,857,674 
Payback Period (year) 2029 2023 2024 2024 2026 2028 
Average Debt Service Cover Ratio 
(ADSCR) 
2.02 48.92 21.86 9.74 4.38 2.75 
Equity Internal Rate of Return (IRR)equity 11.66 38.65 32.52 26.13 19.33 14.86 
Project Internal Rate of Return (IRR)project 10.91 37.47 30.72 24.04 17.44 13.51 
Weighted Average Cost of Capital—
WACC (%) 
6.38 6.98 6.84 6.68 6.51 6.43 
Average Financial Leverage 1.19 0.65 0.76 0.88 1.03 1.13 
(*) not including Value Added Tax, base 2019 (#) including Value Added Tax. 
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Consistently with the described outline, the empirical case will be interpreted with: 
(a) Financial and economic performance analysis. 
(b) Network theory. 
3.2. Financial and Economic Performance Analysis 
The (positive) impact on the overall PF healthcare performance, including bankabil-
ity, is evident from the sensitivity analysis of the main indicators, as a response to the 
improvements in the economic marginality due to digital platforms: 
(a) the Net Present Value (NPV) of the project substantially increases, and so does 
the Internal Rate of Return (IRR) of the project (both parameters incorporate fi-
nancial debt service, being based on operating cash flows), showing respectively 
a greater amount of wealth creation, and a higher hurdle rate compared to a 
break-even WACC; 
(b) even the residual remuneration of shareholders (NPVequity and IRRequity) consist-
ently improves, indicating that after financial debt compensation is positive and 
substantial; 
(c) the payback period shortens, witnessing a lower financial break-even; 
(d) the average debt service coverage ratio substantially grows, showing an excess 
of operating cash flows created each year to properly serve the expiring financial 
debt (the threshold rate is 1); this is possibly the most important parameter for 
bankability, as it shows if and to which extent the SPV can generate enough li-
quidity to properly serve expiring financial debt; 
(e) the financial leverage also decreases, showing a lower ratio of financial debt to 
equity; 
(f) the WACC is the only parameter that (slightly) worsens, but this is just due to a 
weighting adjustment (improved economic/financial margins accelerate debt re-
payment, therefore diminishing the leverage and increasing the equity weights; 
since the cost of equity is higher than the cost of debt, the WACC increases). 
In synthesis, the parameters are highly reactive to financial and economic improve-
ments that affect the overall bankability of the project. Among the reasons for this remarka-
ble sensitivity, we should first consider the long time of the project (28 years, in the example). 
The digital-driven value increase of the “pie” is mainly witnessed by the cumulative 
Net Present Value (in coordination with the other parameters) that can be shared among 
the stakeholders represented in Figure 3: 
• Even if the financial debtholders (mainly represented by the banks that preside over 
the bankability concerns) cannot increase the face value of their credit, they improve 
the likelihood of straightforward debt service that reduces delinquency risk. 
• Sub-contractors follow a similar pattern, with no extra gains but a higher cer-
tainty of being fully paid in due time. 
• Digital platforms are a pass-through virtual B2B2C stakeholder that may receive 
a fixed remuneration. 
• Patients may hope for better care at more competitive prices. 
The two remaining stakeholders that compete for the sharing of the “extra-pie” are 
represented by the backbone of the PPP agreement—the public concessionaire and the 
private SPV—respectively no. 1 and no. 4 of Figure 3 (displayed in paragraph 4.2). The 
incremental NPVequity should accrue exclusively to the (private) shareholders of the SPV, 
whereas the incremental NPVproject should remunerate all the debtholders. As the remu-
neration of the banks and the pass-through suppliers is fixed, the bulk of these extra gains 
accrues to the SPV. Risk management by SPV stakeholders [50] remains a crucial issue 
that savings from digitalization may contribute to softening. 
This simulation represents, however, a simplification of real life, ignoring competition 
among the private participants to the tender, and pressure for the public actor to compen-
sate its real backing stakeholders-patients (that also coincide with … voters). PPP/PF sources 
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of finance are mainly concerned with bank loans. Other healthcare financial sources (uni-
versal healthcare coverage backed by public money; insurance program coverage, etc.) con-
cern the public-patient relationship that is not affected by the PPP/PF architecture. 
Excessive private rents foster auction competition among the private players, to the 
benefit of the public actor that reduces its burden, freeing resources that can be dedicated 
to better healthcare quality, higher outreach (further healthcare investments), or even 
lower taxation. The real ultimate beneficiary of digital-driven extra gains may therefore 
be represented by the public actor. 
3.3. Network Theory Interpretation 
Network theory is the analysis of graphs that illustrate (a)symmetric relations be-
tween discrete objects. In network science and computer science, network theory is in-
cluded in graph theory: a network is routinely defined as a graph whose edges and/or 
nodes (vertices) have attributes (e.g., names). 
A network is interdependent if it is represented by a system of coupled networks 
where nodes of one network depend on vertices in other networks. Networks represent a 
fundamental feature of complex ecosystems. Their interdependent structure could give 
an innovative interpretation of the interactions among different stakeholders. 
Network theory is used in many disciplines, including biology, climatology, ecology, ep-
idemiology, computer science, particle, or statistical physics, electrical engineering, econom-
ics, finance, operations research, and sociology. Network theory can be used in gene regula-
tory networks, metabolic networks, supply chain networks, the World Wide Web, and the 
Internet, social, or epistemological networks, etc. Beyond these traditional areas, network the-
ory can ease the analysis of complex corporate governance structures [13], where composite 
stakeholders interact. This is the case in PPP/PF investments, such as those examined in this 
study. 
The empirical setting may be understood as a theoretical story of healthcare net-
works, providing a complementary explanation of the research question. 
Figures 2 and 3 back the “without-with” comparison, showing—with a simplified 
ecosystem’s wiring diagram—a standard healthcare PPP network, and, respectively, a 
digital network mastered by a platform. 
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Figure 2. Standard Healthcare PPP Network during the Management Phase.  
Legenda 
1. Private to Public invoicing: private income (cash-inflow) and specular public costs (cash-outflows) 
2. Sub-contractors to Private invoicing: private costs (cash-outflows) and sub-contractors income (cash-inflow) 
3. Private to Bank negative interests (costs and cash-outflows) and specular bank to private positive income 
(revenues and cash-inflows); bank to private financing and payback 
4. Private supply to patients of non-core healthcare services 
5. Treasury intermediation (public to private payments are mediated by the banking agent) 
6. Public to the patient supply of services and patient to public payment of tickets 
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Figure 3. Digital Platform Intermediating a Healthcare PPP Network during the Management Phase.  
Legenda 
1 + 4. Private to Public invoicing Through the Digital Platform: private income (cash-inflow) and specular public costs (cash-out-
flows) 
2 + 1. Sub-contractors to Private invoicing through the Digital Platform: private costs (cash-outflows) and sub-contractors income 
(cash-inflow);  
digital B2B auctions are conducted through the platform, with time and cost savings along the digitized supply chain 
3 + 1. Private to Bank negative interests (costs and cash-outflows) and specular bank to private positive income (revenues and cash-
inflows) 
through the Digital Platform; bank to private financing and payback 
1+5. Private supply to patients (and visitors) of non-core healthcare services 
4 + 5. Public to the patient supply of services and patient to public payment of tickets through the Digital Platform 
5. Digital benefits for patients may be detected with Cost-Benefit Analysis and Cost-Effectiveness Analysis [51]. 
6. Direct contact between patients and hospital (for healthcare treatment, etc.). 
7. Indirect relationship between the private actor and the sponsoring banks (not intermediated through the digital platform / 
mobile banking). 
8. Supply of physical goods and services to the private SPV. 
9. Contractual public-to-private agreements. Supply of physical goods and services. 
The compared analysis of Figures 2 and 3 shows that in the latter the digital platform 
acts as an intermediating (bridging) hub, increasing the number of nodes (vertices)—and 
so the overall value and consistency of the network—but especially the quantity and qual-
ity of the links. For instance, any interaction between two agents mediated through the 
platform is digitally recorded in real-time and may fuel big data gathering and artificial 
intelligence elaboration. 
The added value embedded in Figure 3 (compared to Figure 2) can be interpreted with 
network theory analysis [25], with a mathematical measurement of the degree of the nodes 
(number of links with other nodes), and a consequent estimate of their economic value. New 
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connecting nodes with a system’s centrality convey both information and economic trans-
actions, partially reflecting the value increases of the PF parameters, as shown in Table 1. 
The real finite network exemplified in Figure 3 (or even 2) is a complex system, bear-
ing vulnerability due to interconnectivity (any “blackout” concerning the digital platform 
may bring severe problems for the whole ecosystem). The links of Figure 3 (numbered 
from 1 to 9) are bi-directional, therefore increasing the potential flow of data and transac-
tions. A first sight comparison of Figures 2 and 3 shows that the latter graph, mastered by 
the digital platform (acting as a hub or central node) has more nodes and more (intense) 
connections that might be measured from the PF parameters. 
In network (graph) theory, relations among nodes are formulated with an adjacency 
matrix—a square matrix used to show a finite graph as in Figure 2 or Figure 3. The pa-
rameters of the matrix show whether pairs of nodes are adjacent or not in the graphical 
representation. In this case, the adjacency matrix is a symmetric and (0,1)-matrix. Since 
each node is not linked to itself, there are zeros on its diagonal. 
The degree of each node represents the number of links with other nodes and is math-
ematically expressed with a symmetric adjacency matrix that is the following (table 2) for 
Figure 2 (with 5 nodes): 
Table 2. Adjacency matrix of a Standard 5 × 5 PPP Network. 
 a b c d e 
a 0 1 1 1 0 
b 1 0 1 1 1 
c 1 1 0 0 0 
d 1 1 0 0 0 
e 0 1 0 0 0 
However, the symmetric adjacency matrix for Figure 3 (6 nodes) is reported in Table 
3: 
Table 3. Adjacency matrix of a Digitized 6 × 6 PPP Network. 
 a b c d e f 
a 0 1 1 1 1 1 
b 1 0 1 1 0 0 
c 1 1 0 0 1 1 
d 1 1 0 0 0 0 
e 1 0 1 0 0 0 
f 1 0 1 0 0 0 
The value of each network can be estimated with Metcalfe’s law that shows that the 
effect of a network is proportional to the square of the number of connected users 
(nodes) of the system (n2). Therefore, networkFigure 2 = 25, and networkFigure 3 = 36 (consid-
ering, for simplicity, that both networks have the same weights that measure the value 
of each link. This could underrate the effective value of the links of the platform). 
The digital platform, potentially operating always (24/7) and everywhere, reduces paths 
and distances, through its intermediating function that minimizes the number of links among 
the other nodes (shortest path). It also increases the network connectedness, creating addi-
tional paths between otherwise disconnected nodes (for instance, banks and sub-contractors 
that are connected through the platform in Figure 3 but are not connected in Figure 2). 
It is therefore basically shown even in mathematical terms that the digitally mastered 
network outperforms the original (simple) network. The impact on bankability, although 
not directly calculated, is deemed to be positive. This also derives from the network ro-
bustness, fostered by the digital plasticity of resilient platforms. 
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A further extension of the network interpretation of Figures 2 and 3 may be repre-
sented by multilayer networks [52] that are connected thanks to the presence of bridging 































Figure 4. Multilayer PPP networks with a bridging digital platform. 
Figure 4 illustrates the centripetal impact of the digital platform on the layers that get 
closer and superimposed in some areas, sharing some common node, and intensifying 
intra-layer and inter-layer edges. Multilayer networking increases the overall value of the 
PPP ecosystem and may inspire frontier interdisciplinary research. 
4. Discussion 
The empirical simulation has shown that long-termed PF investments are extremely 
sensitive to any change in their economic marginality. The income statement is the real 
“engine” behind the project, mainly because the production of the internal liquidity starts 
from the EBITDA-a financial and economic margin. 
The model proposed in this study can be applied to different healthcare systems that 
may provide or not universal healthcare coverage. This occurs since the relationship be-
tween the public and the private player, which represents the core part of the PPP gov-
ernance network, is not affected by the socio-economic model that links patients to the 
public supplier of healthcare services. The way patient costs are covered (by universal 
healthcare coverage, private insurance companies, or other mixed remuneration patterns) 
does not affect the public–private relationship since patients only interact with the public 
part that runs the hospital. Only ancillary services (Information Communication Technol-
ogy, canteen, laundry, shops, parking, etc.) are run by the private player, within the 
boundaries of the contractual agreements. 
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Highly leveraged investments such as healthcare PF base their capacity to properly 
serve debt on EBITDA-driven self-financing. Although the private players, through their 
SPV, bear most of the entrepreneurial risk, benefits are increasingly shared with the public 
actor and the patients, thanks again to the presence of digital platforms that favor infor-
mation sharing and value co-creation patterns [37,39]. 
The empirical simulation confirms that improved financial and economic marginal-
ity (driven by digital gains) boosts bankability parameters (mainly represented by the 
debt service coverage ratio or the NPV or the leverage). Even if the SPV is a startup, it 
follows a cash-flow pattern (consistent with the PF business plan and the PPP contractual 
agreements) that is different from that of typically unbankable newborn businesses. Crit-
icalities change across time, especially when they concern long-term investments, divided 
into two interdependent phases (project and construction, followed by management). 
Bankability concerns weaken across time since leverage decreases, and debt service is 
fueled by internally generated liquidity (EBITDA). 
Although bankability is formally an issue only for the private part (no money, no 
party), capital rationing criticalities may impede the participation of ailing competitors, 
eventually also damaging the public proponent. Bankability, however, mostly remains a 
private sustainability concern. 
It should be noted, as a caveat, that both Figures 2 and 3 represent, both economically 
and mathematically, a static picture of the PPP framework. A dynamic representation may 
consider first the two distinct phases (construction and operation/management of the hos-
pital), and then the evolution of the financial and economic parameters (it is, for instance, 
well-known that bankability concerns peak at the end of the construction period when 
leverage is maximized and the private SPV has not yet started invoicing for the manage-
ment of the hospital). This represents a hint for future research on the topic. Figure 3 rep-
resents the operational phase since during the construction patients are not present and 
suppliers are different. 
Evolving networks experiment degree dynamics, consistent with each node’s tem-
poral evolution. This does not reflect in the framework represented in Figure 3, where all 
the stakeholders remain unchanged, but the intensity of their relations is modified (the 
bank, for instance, becomes less strategic when its repayment schedule consolidates). 
Some further considerations involve the role of digital platforms and, more generally, 
of technology. These risky investments are mostly undertaken, in a PPP/PF investment 
package, by the private actor, due also to his expertise. The rewards concern both eco-
nomic savings and better care; while the former mostly accrue to the private player (and 
may be partially shared with the public concessionaire), the latter typically benefit the 
patients. Patients and the public player should command a priority because the healthcare 
system is evolving towards patient-centered governance [10] backed by a public actor 
whose budget constraints can be softened mainly by savings. Private rewards for the SPV 
and its sub-contractors should be mitigated by competition and linked to pay-for-perfor-
mance patterns, incentivizing technological upgrades [11]. 
Lessons from the covid-19 pandemic also show the importance of aseptic digital 
stakeholders, such as platforms that ease real-time information sharing. E-health and m-
health applications, pivoting around digital platforms, also favor smart working and so-
cial distancing, contributing to transform, whenever possible, non-acute in-patients into 
out-patients or home-patients [53]. These socio-economic considerations, and their sus-
tainability impact, favor telemedicine applications that ease (whenever possible, always 
excluding emergency treatment or surgical needs) hospital decongestion and avoid un-
necessary traveling. Time-cost savings and quality of life improvements ultimately accrue 
to the patient, a traditionally neglected stakeholder. 
5. Conclusions 
This study analyses the impact of digital savings mastered by networking platforms 
on PPP/PF bankability. Given the multi-faceted financial and institutional pressures for 
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healthcare systems, this type of setting could have important contributions to the research 
and practice of healthcare trends, consistently with the Sustainable Development Goal 3 
(Ensure healthy lives and promote well-being for all at all ages), and with Environmental, 
Social & Governance—ESG targets. 
The paper shows that digital platforms exemplify a bridging node that reshapes the 
networked interaction of connected PPP stakeholders. 
In its industry application, the research concentrates on healthcare investments that 
concern an essential social infrastructure characterized by increasing sustainability issues, 
mainly because of public budgetary pressures, and the aging population. The main result 
is that digitalization creates savings and improves Value for Money (a price/quality ratio), 
softening bankability concerns. Its impact on socio-economic sustainability can be shared 
among the stakeholders, first represented by the patients and the public actors. Should 
the private players try to accumulate excessive rents, taking advantage of the technologi-
cal savings, they would face increased competition, eased by digital comparability that 
reduces information asymmetries. PPP/PF competition is regulated in the contractual bid 
(and then agreement with the private winner) that incorporates the sophisticated regula-
tion prescriptions of the healthcare industry. The feasibility study that precedes the PPP 
auction incorporates the public political-economic factors that are typically complex to 
settle (everybody longs for a new hospital close to home; growing budget constraints are 
to be considered, etc.). 
There are manyfold practical implications of this study. 
First, it is shown that digitalization adds value, with a positive impact on financial and 
economic marginality, therefore improving bankability. This is magnified both by the long-
term schedule of PPP investments, and by the still undetected likelihood that innovation (con-
cerning the synergistic interaction of big data, cloud computing, artificial intelligence, and 
blockchains) could boost productivity in a data- and technology-sensitive industry as 
healthcare. 
Secondly, value co-creation can reward all the stakeholders, improving the Value for 
Money but also the healthcare performance [54–56] in a sector where quality can make the 
difference between survival and death. The benefit extracted from the sharing of the value 
“pie” (with Results-Based Financing, Pay-for-Performance, or other rewarding agree-
ments) represents an incentive for all the stakeholders to nurture a self-fulfilling value co-
creation process, consistent with the representation of Figure 1. 
As anticipated, due to the novelty of the topic and the current lack of track-record 
documentation of smart (platform-driven) healthcare investments, a real case is currently 
not available. This represents a limitation of the study that may be overcome whenever 
evidence becomes available or with appropriate forecasting modeling of current cases up-
graded with technological applications. 
Disruptive technological advances will also contribute to reshaping the digital sup-
ply and value chain, shortening its passages, and producing transactional savings. New 
research streams may be inspired by oncoming evidence of the digital impact on business 
modeling and value creation of innovative PPP patterns. Digital platforms may contribute 
to reshaping the life cycle of healthcare PPP projects, improving their resilience, and sof-
tening the risk concerns that endanger bankability and long-term economic sustainability. 
The findings of this study may be extended to industries outside healthcare [57] or 
generalized to other stakeholder connections [58,59] bridged by digital platforms and in-
terpreted with network theory principles. The role of bridging platforms has hardly been 
investigated in a PPP framework, but it gives an innovative interpretation of the dynamic 
relationships between technology-driven stakeholders. The proposed approach reshapes 
traditional corporate governance models, reinterpreting the theory of the firm (here rep-
resented by the private SPV) in a wider ecosystem, where digitalization eases transactions 
and data diffusion, to the benefit of all the involved stakeholders. 
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Table A1. Impact of healthcare digital platforms. 
Action/Strategy/Device Features and Impact 
1. Inclusion of digital platforms in the 
healthcare supply chain 
Digital platforms enable and improve communication, knowledge generation,
and information diffusion. Digital platforms accessed by a cluster of firms im-
prove cooperation, coordination, and collaboration [60]. Platforms add up in
the network a bridging node whose centrality improves traffic (volume of
transactions, data, etc.). 
2. Digital scalability 
Innovative business models can achieve exponentially increasing returns to
scale as a response to digital disruption, fostering the growth multiplier. Econ-
omies of scale and experience lower the break-even point and foster long-term
sustainability and resilience of the healthcare supply chain, even thanks to m-
health applications [61]. 
3. Electronic health records (remote ac-
cess and use to fuel big data and deci-
sion-making) 
More and more health data are pulled from electronic health records to inform
clinician decision-making. Paperless records are cheaper to store and use ubiq-
uitously [62]. 
4. Inclusion of MedTech, digital health,
and other innovative suppliers 
Digital health’s primary value is to improve the triple aim: better outcomes,
greater access, and affordable care (lower costs). Digital health has the power
to decrease costs by 50% or more [63]. MedTech is a double-edged sword, with
great potential but risky outcomes. MedTech can be effective in cutting
healthcare costs, reduce repetitive tasks, and foster treatment optimization
plans. 
5. Price-based competition with B 
auctions 
Online reverse auctions (with one buyer and many competing sellers) are re-
shaping healthcare. E-auctions reduce transaction costs, ease coordination
among stakeholders. Quality assessment may represent an obstacle to compar-
ative auctions, and therefore standardization, whenever possible, is needed. 
6. Healthcare analytics 
Acquisition and interpretation of (big) data improve the patient experience, de-
crease readmission rates, and provide a better quality of care, bringing to qual-
ity improvements, health cost reduction, and increased patient satisfaction. 
7. M-apps for access and feedbacks 
Providers adopt m-health using mobile apps to ease clinical communication
with patients to improve the management of hospital workflows. Mobile apps
allow effective optimization of communication between providers, patients,
and their caregivers, with a 24/7 personalized management of a patient’s con-
dition. Bottom-up patient feedback (possibly, in real-time) refocus top-down
strategies, fueling big data creation. 
8. Disease management/surveillance 
Epidemic is a complex problem that can be traced using network theory [64].
Disease surveillance increasingly requires m-health devices and strategies.
Prompt identification of patient zero represents, whenever possible, a mighty
target. 
9. Transformation of (non-acute) in-
patients to out-patients and home-
patients 
Chronic patients (suffering from diabetes, cardiovascular diseases, etc.) may
avoid, whenever possible, unnecessary hospitalization, improving m-health
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and remote monitoring [53]. Savings and other socio-economic benefits are po-
tentially enormous. 




Patient-centered interoperability requires new challenges concerning privacy
and security, incentives, technology, and governance that represented a prereq-
uisite for scalability. Blockchain technology might facilitate the exchange of se-
cured data through digital access rules, data aggregation, patient identity, and
data immutability [65]. 
11. Personalized/precision medicine 
Precision/personalized medicine differentiates people into different groups.
Practices, interventions, medical decisions, and/or products are tailored to the
individual patient according to their predicted response or risk of disease. Per-
sonalized medicine can tailor the fittest therapy with the highest safety margin
for better patient care.  
12. Feedbacks from patients (customer 
experience/patient portals) Evaluation 
of treatment effectiveness-assessment 
of patient’s acuity level 
Patients’ feedbacks may derive from data collected through M-apps (see point
7), fostering data mining applications [66]. Feedbacks enhance value co-crea-
tion, reducing information asymmetries and feeding big data. Electronic docu-
mentation can be used to predict patient acuity [67]. 
13. Digital medical devices 
Digital medicine started around 2007 with the introduction of smartphones.
Mobile devices connected with the Internet were incorporated in technology
platforms following telemedicine patterns. Wearable sensors, endowing hand-
held devices with the ability to acquire images and perform lab assays, comple-
ment the framework. This has resulted in a new path for generating in real-
time, and in a real-world environment, medical data by the individual [68]. 
14. Telemedicine, e-health, m-health 
Telemedicine applications are increasingly important in healthcare. Indispen-
sable tools for remote patient monitoring, home healthcare, and disease man-
agement are made available. Applications are fully consistent with networking
digital platforms (see Figures 2 and 3). E-health and m-health may improve
health outcomes (diagnosis, treatment, reduced hospitalization, longer life ex-
pectancy…) 
15. Artificial intelligence applications-
(Early) prediction of pathologies-
digital epidemiology 
Prediction of pathologies can be carried forward with artificial intelligence pat-
terns. Healthcare data and big data analytics are increasingly available, making
the successful applications of AI in healthcare possible. Powerful AI techniques,
driven by relevant clinical questions, can unlock clinically relevant information
hidden in the massive amount of data, assisting clinical decision-making [69].
(Early) prediction of pathologies is enhanced by a combination of MedTech,
precision medicine, patient-centered feedbacks, m-health, etc.  
16. Result-Based Financing (RBF) (Pay-
for-Performance) 
RBF for health consists of a non-monetary transfer or cash payment made to a
manager, provider, or consumer as an incentive to use or deliver priority
healthcare services. Payment is subordinated to measurable actions and bench-
mark savings. Technological applications in a PPP context can produce public
savings that may be partially used to remunerate private players for their non-
routine efforts [11]. 
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